Weekly Paclitaxel Doesn’t Increase Survival in Ovarian Cancer
Paclitaxel administered with carboplatin on a weekly basis is not associated with improved progression-free survival.
Diagnosis & Disease Information
Adding carboplatin to chemotherapy is promising for triple-negative breast cancer
In a study of women with triple-negative breast cancer, adding carboplatin or Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely. This was reported at the 2013 San Antonio Breast Cancer Symposium.
Inclusion of creatinine in blood work during carboplatin treatment
How soon should the creatinine be measured when dosing carboplatin (Paraplatin)?
Radiosensitivity: A new focus on cardiovascular sequelae
An increased risk of coronary artery stenosis in cancer survivors may be a long-term posttreatment effect of chest radiotherapy.
A new era in management of gastrointestinal cancers
Key studies presented at the 2011 Oncology Congress focus on treatments, prevention, and early diagnosis of GI tract cancers.
- Loading...
Loading...
Next post in Gastrointestinal Cancer
Loading... 
Loading...